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Vascular dementia
Current concepts and nomenclature harmonization
Lea Tenenholz Grinberg
ABSTRACT. Several types of cerebrovascular lesions are associated with cognitive decline, but the role of each type in 
dementia manifestation has yet to be determined. One of the greatest barriers of conducting clinicopathological studies 
in vascular dementia concerns the overlapping of nomenclature for these lesions. The aim of the present review was to 
discuss current nomenclature for cerebrovascular lesions and suggest modifications to allow better diagnostic reproducibility 
in this field
Key words: pathology, Alzheimer’s disease, cerebrovascular diseases, vascular dementia.
DEMÊNCIAS VASCULARES: CONCEITOS ATUAIS E HARMONIZAÇÃO DE NOMENCLATURA
RESUMO. Diversas lesões cerebrovasculares estão associadas à perda cognitiva. Entretanto ainda não se conhece qual a 
contribuição exata dessas lesões para quadros os demenciais. Um dos maiores empecilhos para estudos de correlação 
clinicopatológica em demências vasculares é a heteregeonidade de termos usados para definir essas lesões. A presente 
revisão discute a nomenclatura neuropatológica atual para lesões cerebrovasculares e sugere alternativas para melhorar 
a acurácia e reprodutividade do diagnóstico das mesmas.
Palavras-chave: patologia, doença de Alzheimer, demência vascular, doenças cerebrovasculares.
INTRODUCTION
Cerebral arteriosclerosis was considered the main cause of senile dementia in the 
beginning of the twentieth century.1 How-
ever, the demonstration of Alzheimer’s dis-
ease (AD) type as very frequent in control 
elderly and demented subjects led to such an 
extreme shift in this view that for many de-
cades dementia of vascular origin was virtu-
ally dismissed in the differential diagnosis of 
dementia. More recently, vascular dementia 
again became a focus of attention following 
clinicopathological studies showing that even 
a small degree of vascular brain change may 
cause cognitive decline if occurring in a stra-
tegic area.2-3
One of the most important barriers pre-
venting further advances in the understand-
ing of vascular dementia is a lack of a reliable 
way of determining which element of the 
cognitive decline is due to vascular changes. 
Unlike other common causes of dementia, 
vascular dementia is not easily identifiable by 
a specific neuropathological hallmark, such as 
neuritic plaques in AD or Lewy bodies in Par-
kinson’s disease. In addition, vascular chang-
es are also found frequently in brains of cog-
nitively normal elderly,4 making it difficult to 
establish a causal relationship between brain 
lesions and cognitive decline. Moreover, vas-
cular changes are likely to have a synergistic 
rather than an additive effect to primary neu-
rodegenerative processes.5-8 Therefore, a path-
ological diagnosis of vascular dementia (VaD) 
is often reached by excluding other causes. 
A drastic change in the way cerebrovascu-
lar lesions are defined is critical for the cre-
ation of a new set of pathological diagnostic 
criteria.2 Vascular dementia is not a single 
entity, but an umbrella term to describe 
cognitive decline due to a series of different 
vessel disorders, frequently seen in combina-
tion with other non-vascular changes. These 
vessel disorders can induce various types of 
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Figure 1. Example of small 
vessel disease. [A] Subcortical 
white matter exhibiting hyaline 
arteriolosclerosis. Note how the 
arterial wall is thickened by hya-
line material. HE. 200x. [B] Cor-
tex exhibiting cerebral amyloid 
angiopathy. Amyloid-β peptide 
infiltrates the vessel wall. 200x. 
Immunohistochemistry against 
amyloid-β.
A A
cerebral tissue lesions such as hemorrhage, infarction, 
hippocampal sclerosis, and white matter lesions.9
Currently, vascular lesions are classified based on 
their morphological characteristics rather than by their 
pathogenesis. The aims of this review article were to 
review characteristics of cerebrovascular lesions associ-
ated with cognitive decline, discuss overlapping nomen-
clature and propose strategies to harmonize the nomen-
clature adopted for vascular brain disorders.
CURRENT CLASSIFICATION AND NOMENCLATURE 
OF VASCULAR BRAIN DISORDERS
Current classifications distinguish vessel disorders from 
parenchymal lesions. There is a great deal of overlapping 
among the different categories.10-12,14
VESSEL DISORDERS
Vessel disorders are divided into those involving large 
or small vessels.
Large vessel disorders. Atherosclerosis refers to age-re-
lated degenerative vessel disorder of medium- to large-
sized arteries, in which the circle of Willis is the most 
vulnerable site. Atherosclerosis progression follows a 
predictive sequence starting with intima proliferation 
and accumulation of blood-derived lipids and proteins, 
especially cholesterol within vessel walls, resulting in 
atherosclerotic plaques and further degeneration and 
fibrosis of vessel walls.15,16 Atherosclerotic plaques often 
break up leading to thrombosis or emboli.9,17
Small vessel disorders (Figure 1). Small vessel disease (SVD) 
encompasses distinct changes such as small vessel arte-
riosclerosis, arteriolosclerosis, arteriohyalinosis, and li-
pohyalinosis.9,18,19 Arteriosclerosis resembles large vessel 
atherosclerosis, with the exception of calcification.12,20 
Arteriolosclerosis occurs by concentric hyaline thicken-
ing of vessel walls with stenosis of arterioles.20 Lipohya-
linosis is characterized by asymmetric areas of fibrosis, 
hyalinosis associated with foam cells, and accumulation 
of blood-derived lipids and proteins.9,21,22 White matter 
arteries often show loss of smooth muscle cells, fibro-
sis, and thickening of the basement membrane, as well 
as enlarged perivascular spaces with leakage of plasma 
proteins.23
Preferential sites of involvement for SVD are basal 
ganglia, followed by peripheral white matter and lep-
tomeningeal arteries, thalamus and cerebellar white 
matter. Cortical vessels are usually spared.24 SVD is an 
important cause of white matter destruction25,26 and 
Wallerian degeneration.27 More details about SVD pro-
gression can be found elsewhere.24
Sporadic cerebral amyloid angiopathy (CAA) is char-
acterized by amyloid protein, mainly amyloid-β 1-40, 
deposits in cerebral and leptomeningeal artery, vein and 
capillary walls. Typically, these deposits are located near 
the basement membrane or in the smooth muscle cell 
layer.28,29 CAA rarely leads to lethal hemorrhage,28 and 
more often to microbleeds,30 capillary occlusion, blood 
flow disturbances31 and microinfarcts.32 CAA is fre-
quently found together with AD-type changes, but this 
finding is not universal. 
VASCULAR-ASSOCIATED PARENCHYMAL LESIONS 
COMMONLY SEEN IN COGNITIVE DECLINE 
Parenchymal disorders are mainly divided into ischemic 
or hemorrhagic. 
Ischemic. Brain infarcts are subclassified by size into 
large (greater than 1.5 cm3 or 1 cm in diameter), lacunar 
(0.5–1.5 cm3 in volume or 0.5–1.0 cm in diameter) and 
microinfarcts (not seen macroscopically, usually less 
than 0.5 cm in diameter).9,12
Ischemic infarcts (Figure 2) represent the majority 
of large infarcts, and usually follow artery occlusion. 
Infarcts located between the territories of two major 
■    Dement Neuropsychol 2012 September;6(3):122-126
124 Vascular dementia: current concepts    Grinberg LT
arteries are called watershed or borderzone infarcts. 
Clinical manifestation depends on location and ranges 
from motor impairment to language and cognitive dif-
ficulties.33 A recent meta-analysis showed that 10% of 
stroke patients had dementia before their first episode, 
and more than a third developed dementia after recur-
rent strokes.34 
Lacunar infarcts are visible radiologically and upon 
gross examination. They are largely confined to cerebral 
white matter and subcortical structures because the 
lack of anastomoses makes these regions more vulner-
able. It is believed, but not proven, that lacunar infarcts 
are either caused by SVD-related vessel occlusion or by 
embolic events. Certainly, lacunar infarcts are associ-
ated with hypertension9 and may evolve with cognitive 
decline.35,36 The special terms etat lacunaire or status 
lacunaris (when seen in gray matter) and etat crible or 
status cribrosus (when seen in white matter) indicate a 
large number of lacunes in the same region, and have no 
pathogenic meaning.37 
Microinfarcts are often associated with SVD and 
CAA, but can also be caused by thromboembolism.38,39 
They are invisible on gross or imaging examinations and 
most commonly found in the watershed areas of cortex. 
Besides their apparent irrelevance, microinfarcts con-
tribute to cognitive decline.40
Cortical laminar necrosis or pseudolaminar necro-
sis is characterized by neuronal loss and gliosis in the 
neocortex as a consequence of global hypotension or hy-
poxaemia. Therefore, they are most evident at arterial 
borderzones.41
Hippocampal sclerosis (HS) describes abundant neu-
ronal loss without pseudocystic cavitation in the CA1 
sector of the hippocampus and subiculum. Although 
these cells are very sensitive to ischemia, making it logi-
cal to associate cognitive decline to vascular problems, 
they predominate in epilepsy cases, while HS-associated 
frontotemporal lobar degeneration is the form most fre-
quently seen in dementia.42
White matter lesions are found in up to 65% of sub-
jects over 65 years of age, and their frequency increases 
in patients with cerebrovascular disease or cardiovascu-
lar risk. WMLs usually comprise, to varying degrees, de-
myelination, axonal loss, mild reactive astrocytosis, ede-
ma, macrophage reaction, and microangiopathy of the 
penetrating arteries. As a rule, the subcortical U-fibers 
are spared.26,27,43 Binswanger was the first to suggest 
that such changes evolve with cognitive impairment.44
Hemorrhagic. Hemorrhagic infarcts occur after reperfu-
sion of an ischemic infarct or when remaining or collat-
Figure 2. Hemorrhagic infarcts. [A] Coronal section across the thalamus. 
The boxed area encompasses an hemorrhagic infarct. Note how the tissue 
color is darker at this site due to hemosiderin. [B] Histological slide of the 
infarcted area stained for iron. The blue staining represents iron deposits, 
an indirect marker of bleeding. [C] Histological slide of the infarcted area 
stained with HE. The whole area is saturated by hemosiderin (in brown).
A
B
C
eral blood flow is insufficient to keep the infarcted area 
viable and spills into the damaged area.9 Ischemic dam-
age of the vessel walls in the infarct area and impaired 
coagulation mechanisms (e.g. lysis therapy) may facili-
tate blood leakage under the above-mentioned condi-
tions leading to hemorrhagic infarcts. 
Cerebral hemorrhage is a massive blood influx into an 
intact brain parenchyma after vessel rupture. Note that 
infarcts and hemorrhaging are two different processes. 
Dement Neuropsychol 2012 September;6(3):122-126    ■ 
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Large hemorrhages displace brain tissue and are often 
fatal due to brain edema, increased intracranial pressure 
and herniations. Hypertension in arteries involved by 
SVD is the most frequent cause of cerebral hemorrhage, 
followed by CAA.45-48 Aneurysms and vascular malforma-
tions rarely cause hemorrhage in the elderly. Cognition 
related brain areas are usually affected in this process.
Microbleed is the term used to describe either blood 
leakage into perivascular or Virchow-Robin spaces, or 
small intracerebral hemorrhages measuring less than 
10 mm in diameter.49 Microbleeds are age-related and 
believed to be surrogates of microvascular disease, but 
their exact pathogenesis and cognitive impact has yet to 
be clarified50,51 Radiologically, microbleeds can be easily 
detected by magnetic resonance imaging as areas of sig-
nal loss.30 As such, radiologically-detected microbleeds 
in the cortex are indicative of CAA whereas those seen 
in white matter point to SVD.52 Caution should be taken 
in interpreting imaging results, since it has been dem-
onstrated that striatal microbleeds are overestimated 
even on 7.0 T MRI.51
STRATEGIES FOR ALLOWING HARMONIZATION OF  
TERMINOLOGY FOR VESSEL DISORDERS AND 
THEIR ASSOCIATED TISSUE LESIONS
Current terminology for cerebrovascular lesions is based 
on descriptive characteristics, and has a great deal of 
overlap. For instance, atherosclerotic lesions in small ar-
teries can be defined either as atherosclerosis or as small 
vessel disease. Lacunar infarcts are by definition smaller 
than 1.0 cm, but giant lacunae are described in the liter-
ature. Moreover, lacunar infarcts, lacunar hemorrhages, 
and enlarged perivascular spaces with lacunar appear-
ance are all termed lacunes by some authors, despite the 
fact they may be caused by different processes.17
A classification based on pathogenesis is likely to 
ameliorate overlapping problems and enable a more 
readily reproducible set of diagnosis criteria. For in-
stance, hypoxemic lesions should be classified as global 
or local. This scheme would place ischemic infarcts and 
watershed infarcts in different categories (Figure 3). 
An important prerequisite is required before at-
tempting to reclassify cerebrovascular lesions. Current 
methods for neuropathological characterization of 
these lesions differ little to those used a century ago, in 
contrast to the advances seen in methods employed for 
detecting other brain-related conditions such neopla-
sias and neurodegenerative diseases. Therefore, meth-
odological improvement is an essential first step. This 
can be achieved through the development of antibodies 
against certain markers expressed during cerebrovas-
cular lesions or by introducing imaging techniques into 
pathology labs.
A pathogenic-based classification will be beneficial in 
establishing preventive and also therapeutic measures 
against these lesions, and should be prioritized in future 
investigations on vascular dementia. 
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